3803 Parkwood Blvd, Suite 400, Frisco, TX 75034

Supreme Labs

Gastrointestinal Pathogen

Eliminates the need for extra testing for individual pathogens.

Supreme Gastrointestinal (GI) Panel


Gastrointestinal (GI) Panel

Gastrointestinal testing is essential in clinical practices. Our GI panel test identifies 90% of the most common causative bacterial, viral, and parasitic agents of gastroenteritis. We operate on 22 targets, all in one test. Testing is rapid, accurate, and has an overall 98.5% sensitivity and 99.2% specificity. Our pathogen identification has assisted our physicians with more accurate treatments by confidently using our results to make more vital decisions regarding hospital admission, isolation, and antiviral/antibiotic therapy all of which led to better patient satisfaction.

Benefits of Testing

• Eliminates complexity of managing multiple samples

• Eliminates complexity of managing multiple test methods

• Promotes more target therapy

• Leads to more informed patient management decisions

Clients to Benefit from our testing:

• Individuals with high risk of spreading disease in suspected outbreak affecting community’s digestive tract systems - Norovirus

• Individuals in long term care facilities like nursing homes, schools, and summer camps experiencing for example: stomach viruses, stomach flu, food poisoning, and contaminants in public water systems or contamination in streams of water at camp sites - Giardia, Salmonella, Enterocolitica, Cholerae ect..

• Individuals in outdoor events with vendors providing food support causing a possible outbreak of food borne illness - Diarrheagenic E. Coli/Shigella

• General public with recent changes in medical conditions, medicines including antimicrobial treatments and food allergies - C. difficile

• Individuals presenting dysentery causing diarrhea with fever, severe abdominal cramps, blood in stool or signs of sepsis.

• Immunocompromised patients with diarrhea

• Individuals suspected of having Traveler’s diarrhea during traveling in-between countries.



Campylobacter (C. jejuni, C. coli and C. upsaliensis)

Clostridium difficile (C. difficile) toxin A/B

Plesiomonas shigelloides


Yersinia enterocolitica

Vibrio (V. parahaemolyticus, V. vulnificus and V. cholerae) including specific identification of Vibrio cholerae



Cyclospora cayetanensis

Entamoeba histolytica

Giardia lamblia


fiber_manual_recordEnteroaggregative E. coli (EAEC)

fiber_manual_recordEnteropathogenic E. coli (EPEC)

fiber_manual_recordEnterotoxigenic E. coli (ETEC) lt/st

fiber_manual_recordShiga-like toxin-producing E. coli (STEC) stx1/stx2

fiber_manual_recordE. coli O157

fiber_manual_recordShigella/Enteroinvasive E. coli (EIEC)


fiber_manual_recordAdenovirus F40/41 


fiber_manual_recordNorovirus GI/GII

fiber_manual_recordRotavirus A

fiber_manual_recordSapovirus (I, II, IV & V)


Doctors Rarely Receive Accurate or Timely Answers with Traditional Testing

Traditional approaches to identifying the pathogens responsible for enteric infections can be time consuming and lack sensitivity, which can lead to misdiagnosis.

Fast and Accurate Results Can Improve infection 

22% of patients who tested negative for C.difficile and/or rotavirus by conventional testing had a pathogen identified by the SUPREME GI panel. 60% of those patients had not been effectively isolated.

Gastrointestinal Pathogen